We are excited to welcome Professor Tamera Corte to our Scientific Advisory Committee!
Tamera’s extensive expertise in Pulmonary Fibrosis will be an immensely valuable addition to our Scientific Advisory Committee as we continue to develop our pioneering technology to enhance clinical trials and patient outcomes.
With over 15 years’ experience as a respiratory physician, including serving as the Director of Interstitial Lung Disease in the Department of Respiratory Medicine at the Royal Prince Alfred Hospital in Sydney, Tamera is currently Chief Investigator for the Centre of Research Excellence for Pulmonary Fibrosis at the University of Sydney, an institute dedicated to improving the lives of people with pulmonary fibrosis. She is also the founding Chair of the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry and the Australasian Interstitial Lung Disease Registry.
“Qureight’s AI-powered imaging and clinical data curation platform is already accelerating drug development timelines for respiratory diseases. I’m looking forward to working with the team using their innovative approach to improve the lives of people living with Pulmonary Fibrosis,” commented Tamera.